Vesedaganat: vizsgálatok itt: Kína

In Kína 117 Also abroad 486

25 of 117 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.

No phaseNot yet taking people in Kína
Federated Learning in Renal Tumor Model
Where
Guigang, Guilin, Liuzhou, Nanning, Wuzhou
Életkor
18 év to 60 év
People
3000
Run by
First Affiliated Hospital of Guangxi Medical University
See details and how to joinNCT07841756
No phaseNot yet taking people in Kína
Habitat Analysis of Tumor Thrombus for Vena Cava Wall Invasion in Renal Cell Carcinoma
Where
Beijing
Életkor
18 év and over
People
273
Run by
Liu Zhuo
See details and how to joinNCT07901569
No phaseTaking people
Plasma DNA Methylation for Preoperative Classification of Renal Masses
Where
Shanghai
Életkor
18 év and over
People
240
Run by
RenJi Hospital
See details and how to joinNCT07874542
No phaseTaking people
The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy
Where
Beijing
Életkor
18 év to 75 év
People
120
Run by
Peking University First Hospital
See details and how to joinNCT07039474
No phaseTaking people
Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma
Where
Qingdao
Életkor
18 év to 75 év
People
120
Run by
The Affiliated Hospital of Qingdao University
See details and how to joinNCT06916624
No phaseTaking people
An MRI-Based Study of Intelligent Pathological Subtyping and Grading of Renal Tumors
Where
Beijing
Életkor
18 év and over
People
900
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07743749
No phaseTaking people
Expression Levels of Nicotinamide Metabolism-related Protein (NMAP) in Newly Diagnosed Renal Cancer and Non-renal Cancer Populations
Where
Shanghai
Életkor
18 év and over
People
400
Run by
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT04113486
No phaseTaking people
Study on MRD Prediction of Efficacy of Toripalimab in the Treatment of High-risk Recurrent Renal Carcinoma
Where
Tianjin
Életkor
18 év and over
People
110
Run by
Tianjin Medical University Second Hospital
See details and how to joinNCT07657325
No phaseTaking people
Validation of RCC Predicting Model With Emulated-target Trial
Where
Beijing
Életkor
18 év to 80 év
People
4700
Run by
Peking University Third Hospital
See details and how to joinNCT07117227
No phaseTaking people
SABR Combined With Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cancer
Where
Beijing
Életkor
18 év to 85 év
People
300
Run by
Peking University First Hospital
See details and how to joinNCT06583070
No phaseNot yet taking people in Kína
A Multicenter Real-World Study on TKI Therapy After Progression on First-Line TKI/IO Therapy or TKI/IO Therapy After Progression on First-Line TKI in Chinese Patients With Metastatic Renal Cell Carcinoma (mRCC)
Where
Tianjin
Életkor
18 év to 90 év
People
860
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07324876
No phaseNot yet taking people in Kína
AI for Renal Tumors Using Non-Contrast CT
Where
Shanghai
Életkor
18 év to 80 év
People
10 000
Run by
Fudan University
See details and how to joinNCT07304492
No phaseTaking people
Contrast-enhanced Ultrasound and Super-resolution Imaging Predict Renal Function Outcome After Nephrectomy
Where
Nanjing
Életkor
18 év and over
People
285
Run by
Jinling Hospital, China
See details and how to joinNCT07294859
No phaseTaking people
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
Where
Nanjing
People
450
Run by
Jinling Hospital, China
See details and how to joinNCT05917106
No phaseTaking people
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
Where
Nanjing
Életkor
18 év to 80 év
People
39
Run by
Jinling Hospital, China
See details and how to joinNCT06676527
No phaseTaking people
Deep Learning for Automated Discrimination Between Stage T1-T2 and T3 Renal Cell Carcinoma on Contrast-Enhanced CT
Where
Beijing
Életkor
18 év to 85 év
People
1000
Run by
Peking University First Hospital
See details and how to joinNCT07166445
No phaseTaking people
Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment
Where
Wuhan
Életkor
18 év and over
People
400
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07118813
No phaseTaking people
Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)
Where
Chongqing
People
800
Run by
Mingzhao Xiao
See details and how to joinNCT06088134
No phaseTaking people
Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients
Where
Xiamen
Életkor
18 év to 74 év
People
113
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT06956144
No phaseTaking people
Systemic Anti-tumor Activity and Safety of the Combination of SBRT and Concurrent PD-1 Blockade in Metastatic RCC.
Where
Guangzhou
Életkor
18 év and over
People
20
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT06327178
No phaseTaking people
The Value of a Convolutional Neural Network-Based Renal Artery Perfusion Model in Predicting Renal Function After Partial Nephrectomy: A Prospective Study
Where
Nanjing
Életkor
18 év to 80 év
People
300
Run by
Shao Pengfei
See details and how to joinNCT06751498
No phaseTaking people
Optimising Renal Tumour Management Through Artificial Intelligence Modules
Where
Nanjing
Életkor
18 év and over
People
2100
Run by
Shao Pengfei
See details and how to joinNCT06714916
No phaseNot yet taking people in Kína
Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China
Where
Guiyang
Életkor
5 év to 16 év
People
360
Run by
RenJi Hospital
See details and how to joinNCT06873672
No phaseTaking people
Predicting Model Based on Evidence-based Pathological Diagnose Criteria for RCC Tumor Thrombus With IVC Wall Invasion
Where
Beijing
Életkor
18 év and over
People
232
Run by
Peking University Third Hospital
See details and how to joinNCT05589207
No phaseTaking people
Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma
Where
Jinan
People
300
Run by
Qianfoshan Hospital
See details and how to joinNCT05214885